CRB-113

N/A

Report date: 2023/11/29 18:01:30

Base Information

Drug NameCRB-113
Drug Alias NameCRB-113
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelros Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCelros Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A